» Authors » Richard A M Canters

Richard A M Canters

Explore the profile of Richard A M Canters including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 11
Citations 181
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Opbroek T, Willems Y, Verhaegen F, de Ridder R, Hoge C, Melenhorst J, et al.
Clin Transl Radiat Oncol . 2022 Nov; 38:90-95. PMID: 36407490
Background And Purpose: Dose-escalation in rectal cancer (RCa) may result in an increased complete response rate and thereby enable omission of surgery and organ preservation. In order to implement dose-escalation,...
2.
Wolfs C, Canters R, Verhaegen F
Radiother Oncol . 2020 Oct; 153:243-249. PMID: 33011206
Background/purpose: Electronic portal imaging device (EPID) dosimetry aims to detect treatment errors, potentially leading to treatment adaptation. Clinically used threshold classification methods for detecting errors lead to loss of information...
3.
Wolfs C, Varfalvy N, Canters R, Nijsten S, Hattu D, Archambault L, et al.
Med Phys . 2020 Jul; 47(10):4675-4682. PMID: 32654162
Purpose: To externally validate a hidden Markov model (HMM) for classifying gamma analysis results of in vivo electronic portal imaging device (EPID) measurements into different categories of anatomical change for...
4.
van den Ende R, Peters F, Harderwijk E, Rutten H, Bouwmans L, Berbee M, et al.
Radiat Oncol . 2020 Feb; 15(1):41. PMID: 32070386
Background: The STAR-TReC trial is an international multi-center, randomized, phase II study assessing the feasibility of short-course radiotherapy or long-course chemoradiotherapy as an alternative to total mesorectal excision surgery. A...
5.
Van Gellekom M, Canters R, Dankers F, Loopstra A, van der Steen-Banasik E, Haverkort M
Brachytherapy . 2017 May; 17(1):146-153. PMID: 28528720
Purpose: To investigate the feasibility of in vivo dosimetry using microMOSFET dosimeters in patients treated with brachytherapy using two types of gynecological applicators. Methods And Materials: In this study, a...
6.
Paulides M, Stauffer P, Neufeld E, Maccarini P, Kyriakou A, Canters R, et al.
Int J Hyperthermia . 2013 May; 29(4):346-57. PMID: 23672453
Abstract Clinical trials have shown that hyperthermia (HT), i.e. an increase of tissue temperature to 39-44 °C, significantly enhance radiotherapy and chemotherapy effectiveness [1]. Driven by the developments in computational...
7.
Rijnen Z, Bakker J, Canters R, Togni P, Verduijn G, Levendag P, et al.
Int J Hyperthermia . 2013 Apr; 29(3):181-93. PMID: 23590361
Background And Purpose: In Rotterdam, patient-specific hyperthermia (HT) treatment planning (HTP) is applied for all deep head and neck (H&N) HT treatments. In this paper we introduce VEDO (the Visualisation...
8.
Canters R, Paulides M, Franckena M, van der Zee J, van Rhoon G
Int J Hyperthermia . 2012 Jun; 28(6):570-81. PMID: 22690757
Purpose: This manuscript provides an overview in the field of hyperthermia treatment planning (HTP) in cervical cancer. Treatment planning techniques: The workflow of an HTP assisted treatment generally consists of...
9.
Franckena M, Fatehi D, de Bruijne M, Canters R, van Norden Y, Mens J, et al.
Eur J Cancer . 2009 Apr; 45(11):1969-78. PMID: 19361982
Adding hyperthermia to standard radiotherapy (RT+HT) improves treatment outcome for patients with locally advanced cervical cancer (LACC). We investigated the effect of hyperthermia dose on treatment outcome for patients with...
10.
Franckena M, Lutgens L, Koper P, Kleynen C, van der Steen-Banasik E, Jobsen J, et al.
Int J Radiat Oncol Biol Phys . 2008 Nov; 73(1):242-50. PMID: 18990505
Purpose: To report response rate, pelvic tumor control, survival, and late toxicity after treatment with combined radiotherapy and hyperthermia (RHT) for patients with locally advanced cervical carcinoma (LACC) and compare...